CR3 Engaged by PGL-I Triggers Syk-Calcineurin-NFATc to Rewire the Innate Immune Response in Leprosy

Bibliographic Details
Title: CR3 Engaged by PGL-I Triggers Syk-Calcineurin-NFATc to Rewire the Innate Immune Response in Leprosy
Authors: Émilie Doz-Deblauwe, Florence Carreras, Ainhoa Arbues, Aude Remot, Mathieu Epardaud, Wladimir Malaga, Véronique Mayau, Jacques Prandi, Catherine Astarie-Dequeker, Christophe Guilhot, Caroline Demangel, Nathalie Winter
Source: Frontiers in Immunology, Vol 10 (2019)
Publisher Information: Frontiers Media S.A., 2019.
Publication Year: 2019
Collection: LCC:Immunologic diseases. Allergy
Subject Terms: NFAT, Syk, CR3, phenol glycolipid-1, Mycobacterium leprae, dendritic cell, Immunologic diseases. Allergy, RC581-607
More Details: Mycobacterium leprae, the causative agent of leprosy, is unique amongst human pathogens in its capacity to produce the virulence factor phenolic glycolipid (PGL)-I. In addition to mediating bacterial tropism for neurons, PGL-I interacts with Complement Receptor (CR)3 on macrophages (MPs) to promote infection. We demonstrate here that PGL-I binding to CR3 also enhances bacterial invasion of both polymorphonuclear neutrophils (PMNs) and dendritic cells (DCs). Moreover, in all cell types CR3 engagement by PGL-I activates the Syk tyrosine kinase, inducing calcineurin-dependent nuclear translocation of the transcription factor NFATc. This selectively augments the production of IL-2 by DCs, IL-10 by PMNs and IL-1β by MPs. In intranasally-infected mice PGL-I binding to CR3 heightens mycobacterial phagocytosis by lung PMNs and MPs, and stimulates NFATc-controlled production of Syk-dependent cytokines. Our study thus identifies the CR3-Syk-NFATc axis as a novel signaling pathway activated by PGL-I in innate immune cells, rewiring host cytokine responses to M. leprae.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1664-3224
Relation: https://www.frontiersin.org/article/10.3389/fimmu.2019.02913/full; https://doaj.org/toc/1664-3224
DOI: 10.3389/fimmu.2019.02913
Access URL: https://doaj.org/article/8552c01dc9144b9891319eb8b8538c48
Accession Number: edsdoj.8552c01dc9144b9891319eb8b8538c48
Database: Directory of Open Access Journals
More Details
ISSN:16643224
DOI:10.3389/fimmu.2019.02913
Published in:Frontiers in Immunology
Language:English